Clinical Trial Update: Phase I Dose Escalation and Pharmacokinetics Clinical Trial of Mitoxantrone Hydrochloride Liposome in Children With Relapsed and Refractory Lymphoma and Solid Tumors [Phase 1]

View source ↗

Summary

Phase I dose-escalation study and pharmacokinetic assessment of mitoxantrone hydrochloride liposome in children with relapsed/refractory lymphoma and solid tumo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumors

Drugs mentioned

• Mitoxantrone hydrochloride liposome (Mitoxantrone hydrochloride liposome)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Pediatric Solid Tumor | Phase 1 | Status: ACTIVE_NOT_RECRUITING